Seebri and Gabapentin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Seebri (glycopyrrolate) and Gabapentin (gabapentin). Common drug interactions include acute respiratory failure among females and asthma among males.

The phase IV clinical study analyzes what interactions people have when they take Seebri and Gabapentin. It is created by eHealthMe based on reports of 79 people who take the same drugs from the FDA, and is updated regularly.

What is Seebri?

Seebri has active ingredients of glycopyrrolate. eHealthMe is studying from 2,618 Seebri users. Check the latest studies of Seebri.

What is Gabapentin?

Gabapentin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 322,987 Gabapentin users. Check the latest studies of Gabapentin.

On Aug, 02, 2026

79 people who take Seebri and Gabapentin together, and have interactions are studied.

Seebri and Gabapentin drug interactions.

What are the common drug interactions of Seebri and Gabapentin, by gender? *:

female:

Acute respiratory failure
Anaemia (lack of blood)
Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
Anxiety
Bladder prolapse (bulging of one or more of the pelvic organs into the vagina)
Blood glucose decreased
Blood iron decreased
Bone pain
Brain injury
Coma (state of unconsciousness lasting more than six hours)

male:

Asthma
Blood immunoglobulin e increased
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
Sarcoidosis (an inflammatory disease that affects multiple organs in the body, but mostly the lungs and lymph glands)
Cough
Drug ineffective
Dyspnoea exertional (breathlessness or shortness of breath)
Insomnia (sleeplessness)
Lip swelling
Chest discomfort

What are the common drug interactions of Seebri and Gabapentin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Lung disorder (lung disease)
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
Sarcoidosis (an inflammatory disease that affects multiple organs in the body, but mostly the lungs and lymph glands)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Insomnia (sleeplessness)
Cough
Drug ineffective
Dyspnoea exertional (breathlessness or shortness of breath)
Oropharyngeal pain
Arthralgia (joint pain)

30-39:

n/a

40-49:

Anaemia (lack of blood)
Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
Asthma
Bone pain
Crepitations (noises are produced by the rubbing of parts one against the other)
Fatigue (feeling of tiredness)
Gait disturbance
Heart rate increased
Myalgia (muscle pain)
Neck pain

50-59:

Abdominal discomfort
Abdominal pain
Abdominal distension
Asthma
Chest discomfort
Cough
Drug ineffective
Dyspnoea (difficult or laboured respiration)
Dyspnoea exertional (breathlessness or shortness of breath)
Obesity (having too much body fat)

60+:

Dyspnoea (difficult or laboured respiration)
Asthma
Back pain
Chest discomfort
Fall
Forced expiratory volume decreased (decreased lung expired air volume)
Hip fracture
Increased bronchial secretion
Increased upper airway secretion
Intervertebral disc protrusion (spinal disc protrusion)

What are the existing conditions these people have? *

Asthma: 12 people, 15.19%
Pain: 5 people, 6.33%
Ill-Defined Disorder: 5 people, 6.33%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 5 people, 6.33%

* Approximation only. Some reports may have incomplete information.

Do you take Seebri and Gabapentin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously